Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Record History now shows 'No longer looking for participants,' indicating recruitment has ended for the study. It also records a new revision tag 'Revision: v3.6.0' and removes the prior 'Revision: v3.5.5' entry from the history.
    Difference
    0.3%
    Check dated 2026-06-12T13:27:01.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The history page now shows a new release identifier Revision: v3.5.5, replacing the previous v3.5.4. This reflects a software update to the ClinicalTrials.gov interface rather than changes to the trial data or displayed content.
    Difference
    0.1%
    Check dated 2026-06-05T10:21:11.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The record history includes an added Revision: v3.5.4, replacing the prior v3.5.3 in the sequence of revisions.
    Difference
    0.1%
    Check dated 2026-05-14T23:15:19.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page’s interface revision has been updated from v3.5.2 to v3.5.3, reflecting a change to the system/version display rather than any study record content.
    Difference
    0.1%
    Check dated 2026-04-23T21:53:00.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The record history shows the addition of revision v3.5.2 and the deletion of revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:25:05.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:39:19.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.